Literature DB >> 33616600

Approval and Coverage of Cancer Drugs in England, Canada, and the US.

Vinay Prasad1,2, Myung S Kim3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33616600     DOI： 10.1001/jamainternmed.2020.8587

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020.

Authors:  Alyson Haslam; Mark P Lythgoe; Emma Greenstreet Akman; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2021-11-01

2.  Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions.

Authors:  Eirik Joakim Tranvåg; Øystein Ariansen Haaland; Bjarne Robberstad; Ole Frithjof Norheim
Journal:  JAMA Netw Open       Date:  2022-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.